Clinical Research Operations Core

SOL #: 75N93025R00019Pre-Solicitation

Overview

Buyer

Health And Human Services
National Institutes Of Health
NATIONAL INSTITUTES OF HEALTH NIAID
BETHESDA, MD, 20892, United States

Place of Performance

Rockville, MD

NAICS

Research and Development in the Physical (541715)

PSC

Health R&D Services; Health Care Services; Applied Research (AN12)

Set Aside

No set aside specified

Timeline

1
Posted
Jan 13, 2026
2
Response Deadline
Feb 27, 2026, 8:00 PM

Qualification Details

Fit reasons
  • NAICS alignment with historical contract wins in similar service areas.
  • Scope strongly matches core technical capabilities and delivery model.
Risks
  • Past performance thresholds may require one additional teaming partner.
  • Potential clarification needed on staffing minimums before bid/no-bid.
Next steps

Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.

Quick Summary

The National Institute of Allergy and Infectious Diseases (NIAID) is planning a solicitation for Clinical Research Operations Core services. This Presolicitation aims to provide resources and services to implement clinical research, supporting NIAID's mission and public health needs. Responses are due February 27, 2026.

Scope of Work

This effort will support a diverse range of investigators in various scientific areas, enabling them to acquire critical data for funding, partnerships, regulatory compliance, and Phase I/II clinical studies. It will also support NIAID priority activities, including the manufacture and characterization of reagents and products for government-supported clinical trials (e.g., IDCRC), and the wider scientific community.

Contract & Timeline

  • Type: Presolicitation
  • Set-Aside: None specified
  • Response Due: February 27, 2026, 08:00 PM EST
  • Published: January 13, 2026, 12:04 PM EST
  • Place of Performance: Rockville, MD, United States

Additional Notes

NIAID has implemented a Determination of Exceptional Circumstances for preclinical service contracts, requiring a fee-for-service model. Contractors may be required to assign intellectual property filed on third-party materials or new processes/products developed relating to Provider Materials. Public release of results will be delayed until NIAID and the Provider have reviewed and filed patents. While proprietary reagents and processes may be proposed, NIAID and the Provider reserve the right to reject their use.

Contact Information

People

Points of Contact

Cindy HargettPRIMARY
Ignacio Reyes, Contracting OfficerSECONDARY

Files

Files

Download

Versions

Version 1Viewing
Pre-Solicitation
Posted: Jan 13, 2026
Clinical Research Operations Core | GovScope